Mesothelin (MSLN) is a differentiation antigen present on mesothelial cells that is overexpressed in various cancers, including ductal pancreatic, ovarian, and lung tumors, and has been used as a tumor biomarker and target for treatment [132,133]. Here, MSLN is linked to neoplasm.